PDB4 MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETES
Abstract
Authors
J.A. Gaebler G. Soto-Campos P.E. Alperin B.J. Hoogwerf M. Wintle D. Maggs J. Han A. Blickensderfer R. Pencek D. Bruhn B.R. Peskin